Company intelligence / Profile preview

Eutropics Pharmaceuticals

Cambridge, Massachusetts, United Stateseutropics.com ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

Eutropics has developed the PraediCare Dx™ platform—a biomarker technology that enables personalized medicine by predicting patient response to cancer therapies. Their BH3 profiling assay provides a functional biomarker for mitochondrial priming in tumor cells and helps guide both standard-of-care and experimental treatments. The company’s lead therapeutic program targets Mcl‑1 with small molecule inhibitors; diagnostic assays are clinically validated for blood cancers such as AML and CLL

Therapeutic areas: OncologyHematology
Modalities: Small moleculeDiagnostic assay
Industry: Biotech

Drug pipeline

1 asset

EU-5346

Discontinued

Partnerships

Collaborations with pharmaceutical companies and leading academic cancer centers in the U.S., U.K., and Canada to further develop their platform technology

Beyond the preview

Go deeper on Eutropics Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eutropics Pharmaceuticals.

Explore the full profile